A Single Centre, Open-label, Parallel-group, Single Oral Dose Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Pyrimethamine in Healthy Japanese and Caucasian Male Subjects
Phase of Trial: Phase I
Latest Information Update: 13 Oct 2017
At a glance
- Drugs Pyrimethamine (Primary) ; Folinic acid
- Indications Toxoplasmosis
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline
- 09 Oct 2017 Status changed from not yet recruiting to recruiting.
- 22 Sep 2017 Planned initiation date changed from 3 Sep 2017 to 21 Sep 2017.
- 01 Sep 2017 New trial record